RGS9-2 mediates specific inhibition of agonist-induced internalization of D2-dopamine receptors

Journal of Neurochemistry

Volumn 114, Issue 3, 2010, Pages 739-749

  Celver, Jeremy ^a,b   Sharma, Meenakshi ^a   Kovoor, Abraham ^a,b  

^a UNIVERSITY OF RHODE ISLAND   (United States)

^b Kovogen LLC   (United States)

Author keywords

D2 dopamine receptor; delta opioid receptor; G protein coupled receptor; internalization; regulator of G protein signaling 9 2

Indexed keywords

DELTA OPIATE RECEPTOR; DOPAMINE 2 RECEPTOR; RGS 9-2 PROTEIN; RGS PROTEIN; UNCLASSIFIED DRUG; DOPAMINE; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; REGULATOR OF G-PROTEIN SIGNALING 9;

ADDICTION; ARTICLE; CELL STRAIN HEK293; CONTROLLED STUDY; CORPUS STRIATUM; ELECTROPHYSIOLOGY; FLUORESCENCE MICROSCOPY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; INTERNALIZATION; MOOD; MOTIVATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REWARD; SCHIZOPHRENIA; SITE DIRECTED MUTAGENESIS; WESTERN BLOTTING; ANIMAL; CELL LINE; CHEMISTRY; DRUG EFFECTS; ENDOCYTOSIS; FEMALE; METABOLISM; NERVE CELL; OOCYTE; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE; PROTEIN TRANSPORT; XENOPUS LAEVIS;

ANIMALS; CELL LINE; DOPAMINE; DOPAMINE AGONISTS; DOPAMINE D2 RECEPTOR ANTAGONISTS; ENDOCYTOSIS; FEMALE; HUMANS; NEURONS; OOCYTES; PROTEIN STRUCTURE, TERTIARY; PROTEIN TRANSPORT; RECEPTORS, DOPAMINE D2; RGS PROTEINS; XENOPUS LAEVIS;

EID: 77954346676     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2010.06805.x     Document Type: Article

References (56)

1. Anderson G. R., Posokhova E. Martemyanov K. A. (2009) The R7 RGS protein family: multi-subunit regulators of neuronal G protein signaling. Cell Biochem. Biophys. 54, 33 46.
2. Bahia D. S., Sartania N., Ward R. J., Cavalli A., Jones T. L., Druey K. M. Milligan G. (2003) Concerted stimulation and deactivation of pertussis toxin-sensitive G proteins by chimeric G protein-coupled receptor-regulator of G protein signaling 4 fusion proteins: analysis of the contribution of palmitoylated cysteine residues to the GAP activity of RGS4. J. Neurochem. 85, 1289 1298.
3. Ballon D. R., Flanary P. L., Gladue D. P., Konopka J. B., Dohlman H. G. Thorner J. (2006) DEP-domain-mediated regulation of GPCR signaling responses. Cell 126, 1079 1093.
4. Bansal G., Druey K. M. Xie Z. (2007) R4 RGS proteins: regulation of G-protein signaling and beyond. Pharmacol. Ther. 116, 473 495.
5. Beaulieu J. M., Sotnikova T. D., Marion S., Lefkowitz R. J., Gainetdinov R. R. Caron M. G. (2005) An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior. Cell 122, 261 273.
6. Blundell J., Hoang C. V., Potts B., Gold S. J. Powell C. M. (2008) Motor coordination deficits in mice lacking RGS9. Brain Res. 1190, 78 85.
7. Bonci A. Hopf F. W. (2005) The dopamine D2 receptor: new surprises from an old friend. Neuron 47, 335 338.
8. Bouhamdan M., Yan H. D., Yan X. H., Bannon M. J. Andrade R. (2006) Brain-specific regulator of G-protein signaling 9-2 selectively interacts with alpha-actinin-2 to regulate calcium-dependent inactivation of NMDA receptors. J. Neurosci. 26, 2522 2530.
9. Cabrera-Vera T. M., Hernandez S., Earls L. R., Medkova M., Sundgren-Andersson A. K., Surmeier D. J. Hamm H. E. (2004) RGS9-2 modulates D2 dopamine receptor-mediated Ca2+ channel inhibition in rat striatal cholinergic interneurons. Proc. Natl Acad. Sci. USA 101, 16339 16344.
10. Calebiro D., Nikolaev V. O., Persani L. Lohse M. J. (2010) Signaling by internalized G-protein-coupled receptors. Trends Pharmacol. 31, 221 228.
11. Cao T. T., Deacon H. W., Reczek D., Bretscher A. von Zastrow M. (1999) A kinase-regulated PDZ-domain interaction controls endocytic sorting of the beta2-adrenergic receptor. Nature 401, 286 290.
12. Chen S. Hamm H. E. (2006) DEP domains: more than just membrane anchors. Dev. Cell 11, 436 438.
13. Chen C. K., Eversole-Cire P., Zhang H., Mancino V., Chen Y. J., He W., Wensel T. G. Simon M. I. (2003) Instability of GGL domain-containing RGS proteins in mice lacking the G protein beta-subunit Gbeta5. Proc. Natl Acad. Sci. USA 100, 6604 6609.
14. Daigle T. L., Kearn C. S. Mackie K. (2008) Rapid CB1 cannabinoid receptor desensitization defines the time course of ERK1/2 MAP kinase signaling. Neuropharmacology 54, 36 44.
15. Davydov I. V. Varshavsky A. (2000) RGS4 is arginylated and degraded by the N-end rule pathway in vitro. J. Biol. Chem. 275, 22931 22941.
16. De Vries L., Zheng B., Fischer T., Elenko E. Farquhar M. G. (2000) The regulator of G protein signaling family. Annu. Rev. Pharmacol. Toxicol. 40, 235 271.
17. Doupnik C. A., Jaen C. Zhang Q. (2004) Measuring the modulatory effects of RGS proteins on GIRK channels. Methods Enzymol. 389, 131 154.
18. Druey K. M., Blumer K. J., Kang V. H. Kehrl J. H. (1996) Inhibition of G-protein-mediated MAP kinase activation by a new mammalian gene family. Nature 379, 742 746.
19. Geurts M., Hermans E. Maloteaux J. M. (2002) Opposite modulation of regulators of G protein signalling-2 RGS2 and RGS4 expression by dopamine receptors in the rat striatum. Neurosci. Lett. 333, 146 150.
20. Gold S. J., Ni Y. G., Dohlman H. G. Nestler E. J. (1997) Regulators of G-protein signaling (RGS) proteins: region-specific expression of nine subtypes in rat brain. J. Neurosci. 17, 8024 8037.
21. Gold S. J., Hoang C. V., Potts B. W. et al. (2007) RGS9-2 negatively modulates L-3,4-dihydroxyphenylalanine-induced dyskinesia in experimental Parkinson's disease. J. Neurosci. 27, 14338 14348.
22. Gurevich V. V., Gurevich E. V. Cleghorn W. M. (2008) Arrestins as multi-functional signaling adaptors. Handb. Exp. Pharmacol. 186, 15 37.
23. Ho G., Wang Y., Jones P. G. Young K. H. (2007) Activation of serum response element by D2 dopamine receptor is governed by Gbetagamma-mediated MAPK and Rho pathways and regulated by RGS proteins. Pharmacology 79, 114 121.
24. Kearn C. S., Blake-Palmer K., Daniel E., Mackie K. Glass M. (2005) Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors enhances heterodimer formation: a mechanism for receptor cross-talk? Mol. Pharmacol. 67, 1697 1704.
25. Kohout T. A. Lefkowitz R. J. (2003) Regulation of G protein-coupled receptor kinases and arrestins during receptor desensitization. Mol. Pharmacol. 63, 9 18.
26. Kong G., Penn R., Benovic J. L. et al. (1994) A beta-adrenergic receptor kinase dominant negative mutant attenuates desensitization of the beta 2-adrenergic receptor. Agonist-dependent phosphorylation of the mouse delta-opioid receptor: involvement of G protein-coupled receptor kinases but not protein kinase C. Phosphorylation-independent regulation of metabotropic glutamate receptor 5 desensitization and internalization by G protein-coupled receptor kinase 2 in neurons. J. Biol. Chem. 269, 13084 13087.
27. Kovoor A., Nappey V., Kieffer B. L. Chavkin C. (1997) Mu and delta opioid receptors are differentially desensitized by the coexpression of beta-adrenergic receptor kinase 2 and beta-arrestin 2 in xenopus oocytes. J. Biol. Chem. 272, 27605 27611.
28. Kovoor A., Chen C. K., He W., Wensel T. G., Simon M. I. Lester H. A. (2000) Co-expression of Gbeta5 enhances the function of two Ggamma subunit-like domain-containing regulators of G protein signaling proteins. J. Biol. Chem. 275, 3397 3402.
29. Kovoor A., Seyffarth P., Ebert J. et al. (2005) D2 dopamine receptors colocalize regulator of G-protein signaling 9-2 (RGS9-2) via the RGS9 DEP domain, and RGS9 knock-out mice develop dyskinesias associated with dopamine pathways. J. Neurosci. 25, 2157 2165.
30. Krispel C. M., Chen D., Melling N., Chen Y. J., Martemyanov K. A., Quillinan N., Arshavsky V. Y., Wensel T. G., Chen C. K. Burns M. E. (2006) RGS expression rate-limits recovery of rod photoresponses. Neuron 51, 409 416.
31. Missale C., Nash S. R., Robinson S. W., Jaber M. Caron M. G. (1998) Dopamine receptors: from structure to function. Physiol. Rev. 78, 189 225.
32. Natochin M., McEntaffer R. L. Artemyev N. O. (1998) Mutational analysis of the Asn residue essential for RGS protein binding to G-proteins. J. Biol. Chem. 273, 6731 6735.
33. Neve K. A., Seamans J. K. Trantham-Davidson H. (2004) Dopamine receptor signaling. J. Recept. Signal Transduct. Res. 24, 165 205.
34. Nishiguchi K. M., Sandberg M. A., Kooijman A. C., Martemyanov K. A., Pott J. W., Hagstrom S. A., Arshavsky V. Y., Berson E. L. Dryja T. P. (2004) Defects in RGS9 or its anchor protein R9AP in patients with slow photoreceptor deactivation. Nature 427, 75 78.
35. Pei G., Kieffer B. L., Lefkowitz R. J. Freedman N. J. (1995) Agonist-dependent phosphorylation of the mouse delta-opioid receptor: involvement of G protein-coupled receptor kinases but not protein kinase C. Mol. Pharmacol. 48, 173 177.
36. Pitcher J. A., Freedman N. J. Lefkowitz R. J. (1998) G protein-coupled receptor kinases. Annu. Rev. Biochem. 67, 653 692.
37. Posner B. A., Mukhopadhyay S., Tesmer J. J., Gilman A. G. Ross E. M. (1999) Modulation of the affinity and selectivity of RGS protein interaction with G alpha subunits by a conserved asparagine/serine residue. Biochemistry 38, 7773 7779.
38. Psifogeorgou K., Papakosta P., Russo S. J., Neve R. L., Kardassis D., Gold S. J. Zachariou V. (2007) RGS9-2 is a negative modulator of mu-opioid receptor function. J. Neurochem. 103, 617 625.
39. Rahman Z., Gold S. J., Potenza M. N., Cowan C. W., Ni Y. G., He W., Wensel T. G. Nestler E. J. (1999) Cloning and characterization of RGS9-2: a striatal-enriched alternatively spliced product of the RGS9 gene. J. Neurosci. 19, 2016 2026.
40. Rahman Z., Schwarz J., Gold S. J. et al. (2003) RGS9 modulates dopamine signaling in the basal ganglia. Neuron 38, 941 952.
41. Rascol O. Fabre N. (2001) Dyskinesia: L-dopa-induced and tardive dyskinesia. Clin. Neuropharmacol. 24, 313 323.
42. Ribeiro F. M., Ferreira L. T., Paquet M., Cregan T., Ding Q., Gros R. Ferguson S. S. (2009) Phosphorylation-independent regulation of metabotropic glutamate receptor 5 desensitization and internalization by G protein-coupled receptor kinase 2 in neurons. J. Biol. Chem. 284, 23444 23453.
43. Ross E. M. Wilkie T. M. (2000) GTPase-activating proteins for heterotrimeric G proteins: regulators of G protein signaling (RGS) and RGS-like proteins. Annu. Rev. Biochem. 69, 795 827.
44. Seeman P., Schwarz J., Chen J. F. et al. (2006) Psychosis pathways converge via D2high dopamine receptors. Synapse. 60, 319 346.
45. Seeman P., Ko F., Jack E., Greenstein R. Dean B. (2007) Consistent with dopamine supersensitivity, RGS9 expression is diminished in the amphetamine-treated animal model of schizophrenia and in postmortem schizophrenia brain. Synapse 61, 303 309.
46. Snow B. E., Krumins A. M., Brothers G. M., Lee S. F., Wall M. A., Chung S., Mangion J., Arya S., Gilman A. G. Siderovski D. P. (1998) A G protein gamma subunit-like domain shared between RGS11 and other RGS proteins specifies binding to Gbeta5 subunits. Proc. Natl Acad. Sci. USA 95, 13307 13312.
47. Srinivasa S. P., Watson N., Overton M. C. Blumer K. J. (1998) Mechanism of RGS4, a GTPase-activating protein for G protein alpha subunits. J. Biol. Chem. 273, 1529 1533.
48. Taymans J. M., Leysen J. E. Langlois X. (2003) Striatal gene expression of RGS2 and RGS4 is specifically mediated by dopamine D1 and D2 receptors: clues for RGS2 and RGS4 functions. J. Neurochem. 84, 1118 1127.
49. Taymans J. M., Kia H. K., Claes R., Cruz C., Leysen J. Langlois X. (2004) Dopamine receptor-mediated regulation of RGS2 and RGS4 mRNA differentially depends on ascending dopamine projections and time. Eur. J. Neurosci. 19, 2249 2260.
50. Traynor J. R., Terzi D., Caldarone B. J. Zachariou V. (2009) RGS9-2: probing an intracellular modulator of behavior as a drug target. Trends Pharmacol. Sci. 30, 105 111.
51. Vargas G. A. Von Zastrow M. (2004) Identification of a novel endocytic recycling signal in the D1 dopamine receptor. J. Biol. Chem. 279, 37461 37469.
52. Wensel T. G. (2008) Signal transducing membrane complexes of photoreceptor outer segments. Vision Res. 48, 2052 2061.
53. Willars G. B. (2006) Mammalian RGS proteins: multifunctional regulators of cellular signalling. Semin. Cell Dev. Biol. 17, 363 376.
54. Witherow D. S. Slepak V. Z. (2003) A novel kind of G protein heterodimer: the G beta5-RGS complex. Receptors Channels 9, 205 212.
55. Yan Y., Chi P. P. Bourne H. R. (1997) RGS4 inhibits Gq-mediated activation of mitogen-activated protein kinase and phosphoinositide synthesis. J. Biol. Chem. 272, 11924 11927.
56. Zeng W., Xu X., Popov S. et al. (1998) The N-terminal domain of RGS4 confers receptor-selective inhibition of G protein signaling. J. Biol. Chem. 273, 34687 34690. (Pubitemid 29028156)